Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
0.4027
-0.1056 (-20.78%)
Mar 31, 2025, 2:25 PM EDT - Market open
SNSE's stock price has decreased by -61.9% in the past year and price targets may not have had time to catch up.
Sensei Biotherapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$4.25
Upside
+955.38%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Oppenheimer | Oppenheimer | Buy Maintains $3.5 → $4 | Buy | Maintains | $3.5 → $4 | +893.30% | Mar 28, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +893.30% | Mar 28, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +893.30% | Jan 10, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $4 | Strong Buy | Maintains | $4 | +893.30% | Jan 8, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +893.30% | Aug 7, 2024 |
Citigroup | Citigroup | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +893.30% | Jun 3, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +893.30% | May 24, 2024 |
Stephens & Co. | Stephens & Co. | Buy Reiterates $5 | Buy | Reiterates | $5 | +1,141.62% | May 24, 2024 |
Stephens & Co. | Stephens & Co. | Buy Initiates $5 | Buy | Initiates | $5 | +1,141.62% | May 14, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +893.30% | Dec 4, 2023 |
Citigroup | Citigroup | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +1,389.94% | Dec 13, 2022 |
Oppenheimer | Oppenheimer | Hold → Buy Upgrades $5 | Hold → Buy | Upgrades | $5 | +1,141.62% | Oct 3, 2022 |
Piper Sandler | Piper Sandler | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +2,383.24% | Mar 10, 2022 |
Berenberg | Berenberg | Strong Buy → Hold Downgrades $12 | Strong Buy → Hold | Downgrades | $12 | +2,879.89% | Jul 1, 2021 |
Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 29, 2021 |
Oppenheimer | Oppenheimer | Buy Initiates $36 | Buy | Initiates | $36 | +8,839.66% | Mar 1, 2021 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.